{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:23:57Z","timestamp":1791624237202,"version":"4.3.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is the most frequently encountered sustained arrhythmia worldwide. This supraventricular rhythm disorder is precipitated by advanced age, valvular heart disease, hypertension, heart failure, congenital heart defects, and others. However, the role of anabolic steroids (ASs) abuse in precipitating AF remains insufficiently researched and largely underreported, despite their known cardiovascular risks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We present the case of a 40-year-old male bodybuilder who was admitted to the emergency department with symptomatic AF. His medical history revealed the use of ASs, which was suspected to be the trigger. A thorough biological evaluation and echocardiography were performed, revealing no structural or functional cardiac abnormalities. After electrical cardioversion and discontinuation of AS use, the patient\u2019s rhythm returned to normal, with no recurrence of arrhythmia during follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This case highlights the potential but underexplored link between AS use and the onset of AF. Although ASs are known to affect cardiovascular health by promoting hypertension, left ventricular hypertrophy, and endothelial dysfunction, their role in arrhythmogenesis, particularly in AF, remains unclear. In this patient, the absence of other identifiable triggers, combined with the resolution of symptoms upon steroid cessation, strongly suggests a causal relationship. Further research is needed to clarify the mechanisms through which ASs may contribute to the development of AF, particularly in younger, otherwise healthy individuals such as athletes and bodybuilders. This case underscores the importance of awareness among clinicians regarding the potential cardiac risks associated with AS use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae585","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T22:50:57Z","timestamp":1730155857000},"source":"Crossref","is-referenced-by-count":2,"title":["Anabolic steroids as the substrate for atrial fibrillation: a case report"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7795-300X","authenticated-orcid":false,"given":"Manal","family":"Yebari","sequence":"first","affiliation":[{"name":"Emergency Department, Ibn Sina Hospital , Rabat ,","place":["Morocco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-187X","authenticated-orcid":false,"given":"Abderrahmane","family":"Bouchaala","sequence":"additional","affiliation":[{"name":"Emergency Department, Ibn Sina Hospital , Rabat ,","place":["Morocco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-8662","authenticated-orcid":false,"given":"Issam","family":"Berraj","sequence":"additional","affiliation":[{"name":"Emergency Department, Ibn Sina Hospital , Rabat ,","place":["Morocco"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"2024111411365920700_ytae585-B1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024111411365920700_ytae585-B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mcna.2007.09.002","article-title":"Status of the epidemiology of atrial fibrillation","volume":"92","author":"Kannel","year":"2008","journal-title":"Med Clin North Am"},{"key":"2024111411365920700_ytae585-B3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"2024111411365920700_ytae585-B4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/j.1552-4604.1996.tb04167.x","article-title":"Cardiovascular effects of anabolic steroids in weight-trained subjects","volume":"36","author":"Palatini","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"2024111411365920700_ytae585-B5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/17461391.2019.1587522","article-title":"Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes","volume":"19","author":"Christou","year":"2019","journal-title":"Eur J Sport Sci"},{"key":"2024111411365920700_ytae585-B6","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2024111411365920700_ytae585-B7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"2024111411365920700_ytae585-B8","doi-asserted-by":"crossref","first-page":"e023583","DOI":"10.1161\/JAHA.121.023583","article-title":"Thirty-year trends in the incidence of atrial fibrillation: the ARIC study","volume":"11","author":"Ghelani","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024111411365920700_ytae585-B9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198709103171104","article-title":"The natural history of lone atrial fibrillation. A population-based study over three decades","volume":"317","author":"Kopecky","year":"1987","journal-title":"N Engl J Med"},{"key":"2024111411365920700_ytae585-B10","first-page":"380","article-title":"Clinical features and drug therapy in patients with paroxysmal atrial fibrillation; results from the CRAFT multi-center registry","volume":"21","author":"Murgatroyd","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2024111411365920700_ytae585-B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.repce.2016.11.013","article-title":"Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring","volume":"36","author":"Primo","year":"2017","journal-title":"Revista Portuguesa de Cardiologia (English Edition)"},{"key":"2024111411365920700_ytae585-B12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0065-3101(24)00243-3","article-title":"Anabolic steroid abuse","volume":"37","author":"Landry","year":"1990","journal-title":"Adv Pediatr"},{"key":"2024111411365920700_ytae585-B13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1742-1241.1996.tb09532.x","article-title":"Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids","volume":"50","author":"Fisher","year":"1996","journal-title":"Br J Clin Pract"},{"key":"2024111411365920700_ytae585-B14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5694\/j.1326-5377.1993.tb121797.x","article-title":"Anabolic steroid abuse and cardiac death","volume":"158","author":"Kennedy","year":"1993","journal-title":"Med J Aust"},{"key":"2024111411365920700_ytae585-B15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-8703(92)90620-B","article-title":"Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter","volume":"124","author":"Ferenchick","year":"1992","journal-title":"Am Heart J"},{"key":"2024111411365920700_ytae585-B16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-5273(94)90022-1","article-title":"Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builder","volume":"44","author":"Appleby","year":"1994","journal-title":"Int J Cardiol"},{"key":"2024111411365920700_ytae585-B17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1520\/JFS12981J","article-title":"Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings","volume":"35","author":"Luke","year":"1990","journal-title":"J Forensic Sci"},{"key":"2024111411365920700_ytae585-B18","first-page":"115","article-title":"The cardiac toxicity of anabolic steroids","volume":"41","author":"ML S","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"2024111411365920700_ytae585-B19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/2047487316651341","article-title":"Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: a case report and critical review of the literature","volume":"23","author":"Christou","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2024111411365920700_ytae585-B20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0736-4679(99)00095-5","article-title":"Atrial fibrillation and anabolic steroids","volume":"17","author":"Sullivan","year":"1999","journal-title":"J Emerg Med"},{"key":"2024111411365920700_ytae585-B21","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.ijcard.2006.11.199","article-title":"Atrial fibrillation and anabolic steroid abuse","volume":"117","author":"Lau","year":"2007","journal-title":"Int J Cardiol"},{"key":"2024111411365920700_ytae585-B22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsbmb.2004.11.003","article-title":"Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats","volume":"93","author":"Beutel","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024111411365920700_ytae585-B23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00421-005-0111-7","article-title":"Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid","volume":"96","author":"Pereira-Junior","year":"2006","journal-title":"Eur J Appl Physiol"},{"key":"2024111411365920700_ytae585-B24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0002-9149(99)00299-4","article-title":"QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids","volume":"84","author":"Stolt","year":"1999","journal-title":"Am J Cardiol"},{"key":"2024111411365920700_ytae585-B25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijcard.2010.02.039","article-title":"Androgens and atrial fibrillation: friends or foes?","volume":"145","author":"Liu","year":"2010","journal-title":"Int J Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae585\/60179027\/ytae585.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/11\/ytae585\/60665956\/ytae585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/11\/ytae585\/60665956\/ytae585.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:37:28Z","timestamp":1731584248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae585\/7848192"}},"subtitle":[],"editor":[{"given":"Fabian","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Georgios A","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Martin","family":"Manninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Abdullah","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae585","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,28]]},"article-number":"ytae585"}}